Quantbot Technologies’s Provention Bio PRVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-2,120
Closed -$22.4K – 2215
2022
Q4
$22.4K Buy
+2,120
New +$17.1K ﹤0.01% 1427
2021
Q1
– Sell
-298
Closed -$5K – 1863
2020
Q4
$5K Buy
+298
New +$4.47K ﹤0.01% 1168
2020
Q1
– Sell
-1,621
Closed -$24K – 1528
2019
Q4
$24K Buy
+1,621
New +$14.4K ﹤0.01% 1038

Other funds holding PRVB

Quantbot Technologies's PRVB Position: Q1 2023 in Review

Quantbot Technologies sold out of Provention Bio (PRVB) in Q1 2023, closing a stake of 2,120 shares — an estimated $22.4K sold.

Quantbot Technologies first reported a position in PRVB in Q4 2019 and held it in 3 quarters. The position peaked at $24K in Q4 2019. 182 funds tracked by Wall St. Rank hold PRVB as of Q1 2023.

  • Quantbot Technologies reported no remaining Provention Bio position as of Q1 2023 after selling out during the quarter.
  • Quantbot Technologies sold 2,120 Provention Bio shares in Q1 2023, an estimated $22.4K.
  • Quantbot Technologies first reported a position in Provention Bio in Q4 2019 and held it in 3 quarters.
  • Quantbot Technologies's Provention Bio position peaked at $24K in Q4 2019.
  • 182 funds tracked by Wall St. Rank held Provention Bio as of Q1 2023.

Based on Quantbot Technologies's 13F filing for Q1 2023, filed 12 May 2023.